Belite Bio, Inc. (BLTE)

143.85 +1.32 (+0.93%) USD  |  NASDAQ  |  Dec 16, 13:43
More

Belite Bio Total Expenses (Annual)

Total Expenses (Annual) Chart

View Total Expenses (Annual) for BLTE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Annual) Range, Past 5 Years

View Total Expenses (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Annual) Benchmarks

View Total Expenses (Annual) Benchmarks
Start Trial
Ocugen, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
IDEAYA Biosciences, Inc. Upgrade
Janux Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade